DAFNA Capital Management as of Dec. 31, 2021
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 87 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis Com New (STXS) | 21.3 | $85M | 14M | 6.20 | |
| Blueprint Medicines (BPMC) | 5.6 | $22M | 207k | 107.11 | |
| Fate Therapeutics (FATE) | 5.5 | $22M | 372k | 58.51 | |
| Adicet Bio (ACET) | 3.2 | $13M | 733k | 17.49 | |
| Xenon Pharmaceuticals (XENE) | 3.2 | $13M | 403k | 31.24 | |
| Arena Pharmaceuticals Com New | 2.8 | $11M | 120k | 92.94 | |
| Ideaya Biosciences (IDYA) | 2.7 | $11M | 460k | 23.64 | |
| Dex (DXCM) | 2.4 | $9.7M | 18k | 536.94 | |
| Karuna Therapeutics Ord | 2.4 | $9.5M | 72k | 130.99 | |
| Nurix Therapeutics (NRIX) | 2.2 | $8.9M | 306k | 28.95 | |
| Morphic Hldg (MORF) | 2.2 | $8.6M | 182k | 47.38 | |
| Biohaven Pharmaceutical Holding | 2.0 | $8.0M | 58k | 137.81 | |
| Sage Therapeutics (SAGE) | 1.9 | $7.7M | 180k | 42.54 | |
| Merus N V (MRUS) | 1.8 | $7.2M | 226k | 31.80 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $7.1M | 84k | 85.17 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $6.5M | 297k | 21.89 | |
| Ishares Tr Nasdaq Biotech Etf (IBB) | 1.6 | $6.2M | 41k | 152.62 | |
| Cytokinetics Com New (CYTK) | 1.5 | $6.1M | 134k | 45.58 | |
| Cymabay Therapeutics | 1.5 | $6.0M | 1.8M | 3.38 | |
| Cardiovascular Systems | 1.4 | $5.4M | 287k | 18.78 | |
| Revolution Medicines (RVMD) | 1.3 | $5.3M | 212k | 25.17 | |
| AtriCure (ATRC) | 1.3 | $5.0M | 72k | 69.53 | |
| Arcus Biosciences Incorporated (RCUS) | 1.2 | $4.7M | 117k | 40.47 | |
| Mei Pharma Com New | 1.2 | $4.7M | 1.8M | 2.67 | |
| Iveric Bio | 1.2 | $4.6M | 276k | 16.72 | |
| Otonomy | 1.2 | $4.6M | 2.2M | 2.08 | |
| Natus Medical | 1.1 | $4.5M | 191k | 23.73 | |
| Accuray Incorporated (ARAY) | 1.1 | $4.5M | 942k | 4.77 | |
| Radius Health Note 3.000% 9/0 (Principal) | 1.0 | $3.9M | 4.0M | 0.96 | |
| Pardes Biosciences | 1.0 | $3.8M | 234k | 16.37 | |
| F-star Therapeutics | 0.9 | $3.5M | 694k | 5.02 | |
| Alector (ALEC) | 0.8 | $3.2M | 155k | 20.65 | |
| Affimed Therapeutics B V | 0.8 | $3.2M | 571k | 5.52 | |
| Axogen (AXGN) | 0.8 | $3.1M | 332k | 9.37 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $2.5M | 191k | 13.23 | |
| Iteos Therapeutics (ITOS) | 0.6 | $2.5M | 54k | 46.55 | |
| Galapagos Nv Spon Adr (GLPG) | 0.6 | $2.4M | 43k | 55.14 | |
| Biomea Fusion (BMEA) | 0.6 | $2.3M | 314k | 7.45 | |
| Rigel Pharmaceuticals Com New | 0.6 | $2.3M | 879k | 2.65 | |
| Turning Point Therapeutics I | 0.6 | $2.2M | 47k | 47.71 | |
| Athira Pharma (ATHA) | 0.5 | $2.1M | 161k | 13.03 | |
| Viking Therapeutics (VKTX) | 0.5 | $2.1M | 447k | 4.60 | |
| Aerie Pharmaceuticals | 0.5 | $2.0M | 289k | 7.02 | |
| Cogent Biosciences (COGT) | 0.5 | $1.9M | 224k | 8.58 | |
| 89bio (ETNB) | 0.5 | $1.9M | 145k | 13.07 | |
| Kinnate Biopharma | 0.5 | $1.9M | 107k | 17.72 | |
| Mereo Biopharma Group Ads (MREO) | 0.5 | $1.8M | 1.1M | 1.60 | |
| Regulus Therapeutics Com New | 0.4 | $1.7M | 5.6M | 0.32 | |
| Venus Concept | 0.4 | $1.7M | 976k | 1.70 | |
| Century Therapeutics (IPSC) | 0.4 | $1.6M | 100k | 15.86 | |
| Kura Oncology (KURA) | 0.4 | $1.6M | 111k | 14.00 | |
| Brainsway Sponsored Ads (BWAY) | 0.4 | $1.5M | 200k | 7.70 | |
| Surface Oncology | 0.4 | $1.5M | 315k | 4.78 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $1.5M | 11k | 134.55 | |
| Macrogenics (MGNX) | 0.4 | $1.4M | 90k | 16.06 | |
| Ngm Biopharmaceuticals | 0.4 | $1.4M | 81k | 17.71 | |
| Neuronetics (STIM) | 0.4 | $1.4M | 314k | 4.46 | |
| Radius Health Com New | 0.3 | $1.3M | 192k | 6.92 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.3 | $1.2M | 1.5M | 0.83 | |
| Theseus Pharmaceuticals | 0.3 | $1.2M | 98k | 12.68 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $1.2M | 390k | 3.14 | |
| Nextcure (NXTC) | 0.3 | $1.1M | 188k | 6.00 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $1.1M | 206k | 5.33 | |
| Phasebio Pharmaceuticals | 0.2 | $988k | 379k | 2.61 | |
| Masimo Corporation (MASI) | 0.2 | $878k | 3.0k | 292.67 | |
| Mersana Therapeutics (MRSN) | 0.2 | $872k | 140k | 6.22 | |
| Compugen Ord (CGEN) | 0.2 | $866k | 202k | 4.30 | |
| Field Trip Health Ord | 0.2 | $839k | 341k | 2.46 | |
| Aslan Pharmaceuticals Ads | 0.2 | $820k | 733k | 1.12 | |
| Harpoon Therapeutics | 0.2 | $794k | 105k | 7.55 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.2 | $766k | 139k | 5.50 | |
| Larimar Therapeutics (LRMR) | 0.2 | $757k | 70k | 10.79 | |
| Hookipa Pharma Inc equity | 0.2 | $747k | 320k | 2.33 | |
| Scynexis Com New (SCYX) | 0.2 | $740k | 121k | 6.10 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.2 | $685k | 86k | 8.01 | |
| Sutro Biopharma (STRO) | 0.2 | $670k | 45k | 14.89 | |
| Compass Therapeutics (CMPX) | 0.2 | $622k | 196k | 3.17 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $531k | 236k | 2.25 | |
| Pharvaris N V (PHVS) | 0.1 | $528k | 37k | 14.38 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $511k | 136k | 3.75 | |
| Inogen (INGN) | 0.1 | $510k | 15k | 34.00 | |
| Bolt Biotherapeutics (BOLT) | 0.1 | $490k | 100k | 4.90 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $475k | 5.6k | 84.82 | |
| Rti Biologics | 0.1 | $415k | 580k | 0.72 | |
| Annexon (ANNX) | 0.1 | $354k | 31k | 11.49 | |
| Genfit S A Ads (GNFT) | 0.1 | $302k | 60k | 5.00 | |
| Lineage Cell Therapeutics In (LCTX) | 0.0 | $196k | 80k | 2.45 |
